Quantification of HER family receptors in breast cancer

The clinical success of trastuzumab in breast cancer taught us that appropriate tumor evaluation is mandatory for the correct identification of patients eligible for targeted therapies. Although HER2 protein expression by immunohistochemistry (IHC) and gene amplification by fluorescence in situ hybr...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuciforo, Paolo, Radosevic-Robin, Nina, Ng, Tony, Scaltriti, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389676/
https://www.ncbi.nlm.nih.gov/pubmed/25887735
http://dx.doi.org/10.1186/s13058-015-0561-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389676/
https://www.ncbi.nlm.nih.gov/pubmed/25887735
http://dx.doi.org/10.1186/s13058-015-0561-8

Ejemplares similares